<p>We sought to perform epigenomic characterization of prostate cancers by profiling circulating nucleosomes isolated from patient plasma using cell free chromatin immunoprecipitation followed by sequencing (cfChIP-seq). Our major findings include identification of prostate-cancer specific regulatory elements using a novel statistical method accounting for variable tumor DNA fraction in plasma, inferring transcription factor activity based on binding motif enrichment within regulatory elements, and epigenetically phenotyping patients based on clinical and genomic features. Data available in dbGaP will include cfChIP-seq and targeted sequencing from approximately 50 patients with a known diagnosis of cancer and healthy patient controls. <br></p>

Epigenomics of Prostate Cancer from Cell Free Plasma

Prostatic Neoplasms study with ChIP-Seq, Targeted-Capture data on dbGaP (46 participants)

Epigenomics of Prostate Cancer from Cell Free Plasma

Description

Applying For Access

Summary